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Background: Chronic non-bloody diarrhoea affects up to 5% of the population. Microscopic colitis is one of the
most common causes, encompassing the subtypes collagenous colitis and lymphocytic colitis. The diagnosis of
microscopic colitis is made by histological examination of colonic mucosal biopsy specimens. The aim of this
investigation was to determine whether laboratory parameters or questions about disease history or concomitant
disease could be helpful in discriminating patients with MC from those with a histologically normal colonic mucosa.
Findings: Patients admitted for colonoscopy because of chronic non-bloody diarrhoea (>2 loose stools
for >3 weeks) at endoscopy units in Malmö during 2007 and 2009, were enrolled. A total number of 78 patients
were included (60 women, 18 men, median age 59, IQR 45–69 years). Out of these 78, 15 patients (19%) had
microscopic colitis (CC; n = 10, LC; n = 5). MC was especially prevalent in patients above the age of 50 (25%). No
differences were found between those with normal histology and MC in laboratory analyses (inflammatory and liver
parameters). Neither were differences shown in questions regarding symptoms, environmental factors or
concomitant diseases except for an association with celiac disease (p = 0.019) and a trend maybe indicating an
inverse association with appendectomy (p = 0.057).
Conclusions: Microscopic colitis is associated with female gender, celiac disease and consumption of NSAIDs.
Trends were observed indicating that age above 50 years, acute onset and absence of appendectomy may be
associated with MC. No associations were observed with other symptoms, calprotectin levels or liver parameters.
Keywords: Collagenous colitis, Diarrhoea, Inflammatory bowel disease, Lymphocytic colitis, Microscopic colitisFindings
Background
Chronic non-bloody diarrhoea (CNBD) is common in
Western populations. A prevalence of 5% in the back-
ground population and 15% among elderly has been sug-
gested [1]. CNBD is usually defined as more than two
loose stools per day for more than four weeks [2]. The
underlying disease behind CNBD is not always obvious
and can be difficult to diagnose. Besides extra-intestinal
causes, several gastrointestinal conditions may be contem-
plated, such as microscopic colitis (MC), IBS-D (irritable
bowel disease with predominantly diarrhoea) or celiac dis-
ease (CeD). In patients with other complicating diseases* Correspondence: klas.sjoberg@med.lu.se
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unless otherwise stated.secondary diarrhoea may occur, such as bacterial over-
growth in diabetes or bile acid diarrhoea in Crohn’s
disease or as a consequence after cholecystectomy or ileo-
cecal resection [3].
Consequently, even though CNBD may have many
causes, MC is important to contemplate since it is diag-
nosed in 5-20% according to some investigations [4-9].
Histological characteristics of MC are well defined [10].
The condition can be divided into two subgroups; col-
lagenous colitis (CC) and lymphocytic colitis (LC). Col-
lagenous colitis was first described as a case report by
CG Lindström in 1976 [11] and LC by Lazenby et al. in
1989 [12]. In MC a macroscopically normal or near nor-
mal mucosa is observed [10]. Weight loss and abdominal
pain may occur [13,14]. Since it is possible to verify sus-
pected MC first after examination of biopsy specimensLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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laboratory parameters would be helpful.
Occasional previous investigations on patients with ac-
tive MC have noticed a slight elevation in the calprotec-
tin levels, indicating an inflammatory response [15,16].
Even if this test theoretically could be used for diagnos-
tic purposes it is somewhat complicated and if blood
samples could be used instead it would probably be pre-
ferred by the majority of the patients. In view of the
presence of this low grade inflammation an increase in
sedimentation rate, CRP, number of white blood cells or
aberrations in the differential count could be contem-
plated. However, limited data are available regarding la-
boratory and clinical characteristics in MC. In contrast
to classic inflammatory bowel disease (IBD), where dis-
turbed liver function may occur, no information is, to
the best of our knowledge, available in MC.
Research hypothesis
Since MC is manifested through inflammatory activity in
colon we imagined that this inflammatory activity could
be detected in some way in blood and fecal samples as
well. We also imagined that the symptoms, environmen-
tal factors, frequency of concomitant diseases (especially
diseases considered as autoimmune) as well as charac-
teristics of disease onset would differ from patients with
CNBD but with histologically normal colonic mucosa.
Methods used
Patients admitted for colonoscopy at out-patient clinics
(either to private Endoscopy Units in Malmö or to the
Endoscopy unit at the Dept of Gastroenterology and
Nutrition at Skåne University Hospital, Malmö) because
of CNBD from January 2007 until June 2009 were in-
vited to this investigation. CNDB was defined as more
than two loose stools per day for more than three weeks,
where blood not had been detected. Those willing to
participate were asked to answer a questionnaire about
their past and present medical history and also left blood
and fecal samples.
A self administrated questionnaire about chronic diar-
rhoea onset (acute or slow), stool frequency (“high” if
more than 10 stools/day), stools at night and consistency
was completed by the patients. They were also asked
questions about recent journeys abroad (i.e. a journey
abroad within a month before onset of symptoms) and
about “surrounding cases of diarrhoea” (if anyone in the
immediate surroundings had had onset of diarrhoea at
the same time as the patient). A list of different potential
co-factors was also penetrated, such as smoking habits,
previous surgery (cholecystectomy or appendectomy),
and presence of celiac disease, thyroid disease, rheuma-
toid arthritis or diabetes mellitus. Medical treatment was
also taken into consideration with questions concerningongoing drug treatment. Three to four years later the pa-
tients were asked whether they had recovered or not (total
recovery or a reduction of symptoms three to four years
after colonoscopy compared to before colonoscopy).
Blood and fecal samples were collected prior to colonos-
copy. C-reactive protein (CRP), sedimentation rate, haemo-
globin, white blood cells with differential count, platelets,
creatinine, aspartate transaminase (AST), alanine trans-
aminase (ALT), alkaline phosphatase (ALP), bilirubin as
well as fecal calprotectin were analysed at the Department
of Clinical Chemistry, Skåne University Hospital Malmö,
according to standardized procedures. Calprotectin was
analyzed according to the procedure described by Tøn
et al. [17].
During colonoscopy mucosal biopsy specimen were
obtained from distal ileum, caecum, ascending colon,
right flexure, transverse colon, left flexure, descending
colon, sigmoid colon as well as rectum with at least two
biopsies from each location.
The histopathological criteria used for CC were:
 A thickened subepithelial collagen layer ≥ 10
micrometers (μm)
 A chronic inflammatory infiltrate in the lamina
propria
 Epithelial damage such as flattening and detachment
The histopathological criteria used for LC were:
 Intraepithelial lymphocytes (IEL) ≥ 20 per 100
surface epithelial cells
 A subepithelial collagen layer < 10 μm
 A chronic inflammatory infiltrate in the lamina propria
 Epithelial damage such as flattening and detachment
The specimens were evaluated by a gastrointestinal
pathologist with a special interest in MC (M Olesen). The
subepithelial collagen layer was measured with an ocular
micrometer in a well orientated part of a mucosal section.
Measurement of the collagen layer as well as counting of
IEL was performed in haematoxylin-eosin. Whenever con-
sidered necessary special stainings for collagen fibres
(Masson’s trichrome or van Gieson) or reticulin fibres
(Sirius red) were carried out. Whenever considered needed
sections were immunohistochemically stained with anti-
bodies against T-lymphocytes (CD3) [10]. Diagnoses of
ulcerative colitis or Crohn’s disease were set according to
established criteria previously described in detail [18].
The investigation was approved by the local Commit-
tee of Research Ethics at Lund University (LU: 276/
2006). The patients were included first after written in-
formed consent.
For analyses of differences between patients with MC and
those with a normal colonoscopy based on macroscopic
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were excluded) Kruskall-Wallis’ non-parametric test was
used. Chi2 analysis was used to compare frequencies of
MC in different age groups. A p-value below 0.05 was
considered significant.
Results
During the study period 397 patients were admitted for
colonoscopy with CNBD. Of these 176 did not answer
(mean age 47 years, 108 females (61%)), 110 actively de-
nied participation (mean age 58 years, 80 females (73%))
and 33 cancelled their colonoscopy (mean age 54 years,Table 1 Laboratory values in patients with microscopic colitis
mucosa
Total number Median
SR 1 44 9.5
(<20 mm) 2 12 5.5
CRP 1 45 2.5
(<3.0 mg/L) 2 12 1.8
F-Calprotecin 1 43 32
(<50 μg/g) 2 12 38.5
Haemoglobin 1 47 137
(♀: 117-153 ♂: 134–170 g/L) 2 12 134
Leukocytes 1 47 6.9
(3.5-8.8 g/L) 2 12 6.8
Neutrophils 1 47 4.1
(1.7-8.0 x10^9/L) 2 12 4.0
Eosinophils 1 46 0.10
(0.1-0.6 x10^9/L) 2 12 0.10
Basophils 1 47 0.10
(<0.2 x10^9/L) 2 12 0.10
Lymphocytes 1 47 1.8
(1.1-4.8 x10^9/L) 2 12 2.2
Monocytes 1 45 0.50
(0.1-1.0 x10^9/L) 2 12 0.50
Platelets 1 47 253
(145–348 x10^9/L) 2 11 273
Bilirubin 1 47 11
(5–25 μmol/L) 2 12 12
AST 1 47 0.39
(0.25-0.75 μkat/L) 2 12 0.42
ALT 1 47 0.39
(0.15-1.1 μkat/L) 2 12 0.36
ALP 1 44 1.2
(0.60-1.8 μkat/L) 2 12 1.1
1 = normal histology, 2 = MC.
CRP = C-reactive protein, AST = aspartate transaminase ALT = alanine transaminase A
11 of 58 with normal histology did not leave blood and fecal samples.
3 of the 15 MC-patients did not leave blood and fecal samples.20 females (61%)). The mean age of all drop-outs was 52
years, and 65% were females (range 18–89 years). The
cohort that finally agreed to participate in the study and
completed both colonoscopy and questionnaires con-
sisted of 78 patients, mean age 56 years, 60 women
(77%), 18 men (range 18–88 years). The number of in-
cluded patients that provided blood/fecal samples and
answered the questions are stated in Tables 1 and 2.
The final diagnoses in the cohort are given in Table 3.
Among patients below the age of 50, four out of 26
(15%) had classic IBD (two with Crohn’s disease and two
with ulcerative colitis) but only two (8%) had MC, onecompared to those with histologically normal colonic
IQR Mean Std. Deviation P-values
7.25; 17.75 13.2 8.4
4.25; 21 10.9 10.3 0.13
1.0; 4.9 4.4 5.5
0.72; 4.8 2.6 2.2 0.51
20; 66 58.6 66.4
20; 114 67.8 68.5 0.71
129; 141 135.3 11.4
127; 142 133.8 10.8 0.87
5.7; 7.8 6.9 1.9
5.8; 9.5 7.3 2.1 0.74
3.2; 5.4 4.4 1.7
2.8; 5.7 4.4 1.7 0.98
0.10; 0.20 0.2 0.1
0.10; 0.20 0.2 0.1 0.56
0.10; 0.10 0.1 0.0
0.10; 0.10 0.1 0.0 1.0
1.5; 2.1 1.9 0.6
1.9; 2.4 2.2 0.6 0.41
0.40; 0.60 0.5 0.2
0.40; 0.50 0.5 0.2 0.87
233: 296 273.6 75.3
229; 319 271.9 47.9 0.57
9; 13 11.6 3.4
8; 14 12.3 4.9 0.94
0.33; 0.45 0.4 0.1
0.30; 0.46 0.4 0.1 0.87
0.33; 0.49 0.4 0.3
0.22; 0.52 0.4 0.2 0.45
1.0; 1.4 1.2 0.3
0.8; 1.4 1.2 0.4 0.34
LP = alkaline phosphatise.
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ses in the population have been listed. In contrast to this
finding, in patients 50 years old or older only one out of
52 had Crohn’s disease (2%) but as many as 13 (25%)
had MC; nine CC and four LC (p = 0.067). The age and
sex distributions in patients with normal histology and
CC and LC, respectively, are depicted in Table 4. As can
be seen in this Table the patients with MC were all
women compared to 41 out of 58 in those with normal
histology (p = 0.017).
Patients with MC (n = 15) were compared with pa-
tients with normal histology (where also patients withTable 2 Questionnaires’ outcome in patients with microscopic
colonic mucosa
Total number
Acute onset 1 56
2 12
High frequency 1 58
2 13
Watery diarrhoea 1 58
2 13
Nocturnal diarrhoea 1 38
2 6
Abdominal pain 1 58
2 15
Surrounding cases 1 57
2 13
Recent journey 1 58
2 12








Celiac disease 1 49
2 10
Thyroid disease 1 52
2 12
Rheumatoid arthritis 1 50
2 13




1 = normal histology, 2 = MC.adenoma and diverticula were included, n = 58) regard-
ing laboratory levels and outcome of the questionnaire
as stated above. The association with celiac disease was
confirmed. There was a trend that patients with MC had
an acute disease onset and an inverse correlation with
appendectomy. See Tables 1 and 2.
The drugs used by the patients with MC was compared
with those in patients with normal histology regarding
NSAIDs, ASA, paracetamol, tramadol, antidepressants,
PPI, other antacids, medicines regulating blood pressure,
diabetes and elevated blood lipids, loperamide, bensodia-
zepins, folic acid, vitamin B12, calcium and bulking agents.colitis compared to those with histologically normal










































Lymphocytic colitis 5 (1 CeD)
Celiac disease 2 (1 LC)
Further investigation 16
IBS-D 6





Diagnosis not stated in pat files 16
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where 9/15 with MC (60%) used NSAIDs compared to 9/
56 (16%) in those with normal histology (p = 0.001).
Discussion
The aim of this study was to find predictors for MC in a
population with CNBD. None of the laboratory analyses
revealed any differences between patients with MC and
those with a histologically normal colonic mucosa
(Table 1). Previous investigations have noticed an eleva-
tion of calprotectin. Wildt et al. reported a median level
of 80 ug/g [16] and Limburg et al. observed a median
value of 266 ug/g [15] in active MC. In the present study
the median value in active MC was only 38 ug/g com-
pared to 32 in patients with histologically normal co-
lonic mucosa, despite the fact that the same method [17]
from Norway has been used in the present report as well
as the one by Limburg et al. If this is due to variation be-
cause of low sample size or comparison with different
cohorts with symptomatic diarrhoea due to otherTable 4 Age in patients with microscopic colitis compared
to those with histologically normal colonic mucosa
CC LC Normal
Total number 10 5 58
♀/♂ 10/0 5/0 41/17
Age at onset (median) 61 50 55
IQR 53, 69 38, 57 34, 65
Age at colonoscopy (median) 69 58 59
IQR 55, 72 50, 58 46, 69diseases is not possible to conclude from the available
data. However, this 36.5-kD nonglycosylated polypeptide
trimer [15] is predominantly found in neutrophils, mainly
activated in some acute inflammatory responses such as in
classic IBD. The fact that we, in our study, could not see
any elevation of calprotectin can therefore be explained by
the fact that MC is primarily characterized by a chronic
inflammation dominated by lymphocytes without any
acute inflammatory response including neutrophils. Fur-
thermore, liver disease does not seem to be associated
with MC. This observation has not to the best of our
knowledge been previously presented elsewhere.
Among patients with MC 31% smoked compared to
22% among those with normal histology although this
did not reach statistical significance (p = 0.18). NSAIDs
were used to a higher extent among MC patients. This is
in accordance with previous studies [19] but also similar
to the situation in classic IBD where the risk for active
disease is increased if NSAIDs are administered. There
was a trend that appendectomy could be inversely corre-
lated with MC (31% in patients with normal histology
compared with 6.7% in patients with MC, p = 0.057).
This possible association has not been studied exten-
sively but in a population of 130 patients with MC no
association was found, in that report neither for chole-
cystectomy nor for appendectomy [20]. Nevertheless, in
view of the association between Crohn’s disease and ap-
pendectomy this observation warrants further studies in
order to verify if there really is any association or not.
Celiac disease was more frequent in MC (p = 0.019),
something that has been noticed in other reports as
well [13,21].
This investigation has verified a substantial occurrence
of MC in a cohort with chronic non-bloody diarrhoea. In
15 patients (19%) collagenous or lymphocytic colitis were
revealed (10 with CC and 5 with LC). During the period
1993–97 Fernandez et al. found 24 (6%) with CC and 38
with LC (10%) among 375 patients investigated for
chronic diarrhoea [6]. Frequencies of 10% have been sug-
gested in two other investigations; 97 out of 1018 [8] and
27 out of 265 patients [7], respectively. Thijs identified 13
out of 103 (12.6%) [9]. da Silva et al. identified 12% with
CC and 7% with LC in 162 patients investigated because
of chronic diarrhoea based on the same criteria as ours
[4]. Consequently, the proportion of MC in our study is at
least in line with the above mentioned previous investiga-
tions underlining the fact that MC should be regarded as a
possible diagnosis in these patients.
It should be noted that the group investigated in this
study consisted of 60 women (77%) with a median age of
60 years, in other words patients where MC is especially
prevalent. The demography in our study can be com-
pared to those in some of the other reports; Fernandez
investigated a group with a mean age of 56 years, 63%






Age above 50 years
No appendectomy
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45 years, 64% women (13% MC) [9] and da Silva a group
with a mean age of 44 years, 59% women (19% MC) [4].
The skewed distribution in age and gender in all these
groups reflects the fact that those attending health care
because of CNBD primarily are middle-aged or older
women.
If the cut-off level is set at 50 years of age the preva-
lence of MC in patients above this level is markedly
high; 25% had MC compared to 8% in those below the
age of 50. In this patient group it is thus especially im-
portant to consider the possibility of MC. Actually; this
particular cut-off level has been suggested previously in
a literature review aimed at establishing recommenda-
tions for investigation of chronic diarrhoea [22], even
though the prevalence increases even more above the
age of 70 [8].
A weakness of the present report is the number of in-
cluded patients. In order to enrol a sufficient number of
patients almost 400 patients were invited. A reasonable
response rate should have resulted in around 300 pa-
tients but for different reasons the final number was
below 100. Some cancelled their investigation, some
never answered the invitation despite reminders. Yet
other actively denied participation and in some cases
this could be due to other research projects exhausting
the patients. Despite the limited number of participants
there are some significant observations that could be of
interest for further studies.
Conclusions
The conclusions of the present report are depicted in
Table 5.
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